A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Metamizole
The risk or severity of gastrointestinal irritation can be increased when Prednisolone acetate is combined with Metamizole.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Benoxaprofen
The risk or severity of gastrointestinal irritation can be increased when Prednisolone acetate is combined with Benoxaprofen.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Nimesulide
The risk or severity of gastrointestinal irritation can be increased when Prednisolone acetate is combined with Nimesulide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Licofelone
The risk or severity of gastrointestinal irritation can be increased when Prednisolone acetate is combined with Licofelone.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Taxifolin
The risk or severity of gastrointestinal irritation can be increased when Prednisolone acetate is combined with Taxifolin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Azosemide
The risk or severity of hypokalemia can be increased when Prednisolone acetate is combined with Azosemide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Piretanide
The risk or severity of hypokalemia can be increased when Prednisolone acetate is combined with Piretanide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
GLPG-0492
The risk or severity of fluid retention can be increased when Prednisolone acetate is combined with GLPG-0492.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Stanozolol
The risk or severity of fluid retention can be increased when Prednisolone acetate is combined with Stanozolol.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Oxymetholone
The risk or severity of fluid retention can be increased when Prednisolone acetate is combined with Oxymetholone.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Epitizide
Prednisolone acetate may increase the hypokalemic activities of Epitizide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Pipemidic acid
The risk or severity of tendinopathy can be increased when Prednisolone acetate is combined with Pipemidic acid.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Rufloxacin
The risk or severity of tendinopathy can be increased when Prednisolone acetate is combined with Rufloxacin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Oxolinic acid
The risk or severity of tendinopathy can be increased when Prednisolone acetate is combined with Oxolinic acid.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Sitafloxacin
The risk or severity of tendinopathy can be increased when Prednisolone acetate is combined with Sitafloxacin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Prulifloxacin
The risk or severity of tendinopathy can be increased when Prednisolone acetate is combined with Prulifloxacin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Pazufloxacin
The risk or severity of tendinopathy can be increased when Prednisolone acetate is combined with Pazufloxacin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Difloxacin
The risk or severity of tendinopathy can be increased when Prednisolone acetate is combined with Difloxacin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Sarafloxacin
The risk or severity of tendinopathy can be increased when Prednisolone acetate is combined with Sarafloxacin.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Orbifloxacin
The risk or severity of tendinopathy can be increased when Prednisolone acetate is combined with Orbifloxacin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3